Trials / Completed
CompletedNCT01012141
Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer
Pilot Phase II Study of Docetaxel in Combination With a Dietary Phytonutrient in First Line Treatment of Hormone Independent Metastatic Prostate Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Centre Jean Perrin · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE : Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Dietary supplements, such as phytochemicals, may stop or delay the development of prostate cancer.
Detailed description
The purpose of this study is to assess the pathological response rate in metastatic prostate cancer patients treated by : Docetaxel with a phytochemical
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | phytochemical | |
| DRUG | Docetaxel |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2009-11-11
- Last updated
- 2013-04-10
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01012141. Inclusion in this directory is not an endorsement.